Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-022-6 | CAS number: 473278-76-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Neurotoxicity
Administrative data
Description of key information
similar to OECD 424, oral, rat, 90 -days: NOAEL = 996 mg/kg bw/day (highest dose tested)
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 996 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- The available information comprises adequate, reliable (Klimisch score 1) and consistent study, and is thus sufficient to fulfil the standard information requirements set out in Annex VIII-IX, 8.6, of Regulation (EC) No 1907/2006.
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The study was designed to investigate the possible neurotoxicity of the test material and was conducted similar to OECD TG 424. The test material was administered by dietary admixture to three groups, each with ten male and ten female Sprague-Dawley Crl:CD® (SD) IGS BR strain rats, for up to 90 consecutive days (13 weeks), at dietary concentrations of 150, 1500 and 12000 ppm (equivalent to a mean achieved dosage for males and females of 12, 117 and 996 mg/kg/day, respectively). A further group of ten males and ten females was exposed to basal laboratory diet to serve as a control.
There were three unscheduled deaths during the study but these were not attributed to neurotoxicity. The three interim deaths of male rats at 12000 ppm were attributed to physical injury (an open wound to the tail, broken teeth and tongue injury). Normally, such injuries would not have resulted in death, however, the blood was reported as thin and pale for one of these animals, suggesting an adverse effect on clotting potential. However, this was a systemic effect of treatment and was not indicative of neurotoxicity. Clinically observable signs were confined to opacity of the eyes and varying degrees of fur loss. A treatment-related reduction in bodyweight for animals of either sex treated with 12000 ppm was considered to be attributable to the effects of administration, due to a reduction in food efficiency in the same group. Temporary reduction in bodyweight gain at the early stages for groups treated with 1500 ppm was probably attributable to the unpalatable nature of the dietary admixture and was not a direct effect of toxicity. Ophthalmoscopic examination revealed opacity and neovascularisation of the cornea, throughout the treatment groups, with effects more severe at 150 and 1500 ppm. This was considered to be attributable to the effects of administration of the dietary admixture. Diet residue may have been accidentally deposited in and around the eyes, causing irritation. Neovascularisation is a mechanism which promotes corneal healing and is a common pathological response following corneal insult. A reduction in absolute brain weight was detected at all treatment levels. This was most probably due to the lower bodyweight gains seen during the first week of the study and not a neurotoxic effect of treatment. In addition, necropsy findings from 12000 ppm animals showed thickening of the glandular gastric epithelium. Histopathological examination showed no evidence of neurotoxicologically significant ocular or gastric change and neural tissue of 12000 ppm animals was similar to that of controls. No toxicologically significant microscopic changes were detected.
Conclusion: Since no neurotoxic effects were observed up to the highest dose level, a 'No Observed Adverse Effect Level' (NOAEL) of 12000 ppm (equivalent to a mean achieved dosage of 996 mg/kg bw/day) for neurotoxicity was derived.Justification for classification or non-classification
The available data on neurotoxicity with 2-{2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy)methyl]benzoyl}cyclohexane-1,3-dione (CAS 473278-76-1) does not meet the criteria for classification according to Regulation (EC) No 1272/2008, and is therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
